Adverse event in Serum's trial won't affect vaccine timelines: Health secy

Health ministry to come out with guidelines that will address the issues around vaccine safety to create awareness and dispel misinformation

The initial assessment of the adverse event in the ‘Covishield’ vaccine trials being conducted by the Serum Institute of India (SII) did not necessitate the stoppage of the trial and it has in no way impacted the timelines of the vaccine’s roll out plans, the government officials said on Tuesday. 

“Due processes were followed in reporting the adverse event... We have been given to understand that there is a court case so we cannot comment on the specifics of the case,” said Rajesh Bhushan, secretary, health and family welfare ministry while addressing a press conference on the Covid-19 situation in